A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
Clinical trial NCT05966740 · TERMINATED
Trial details
- NCT number
- NCT05966740
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-19
- Primary completion
- 2025-04-28
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.